Abbott | ABT - Trade Creditors


Abbott reported $4.68B in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Agilent USD 615M 13M Mar/2026
AtriCure USD 78.74M 8.68M Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Becton, Dickinson and Co. USD 5.93B 204M Mar/2026
Bio-Rad Laboratories USD 143.5M 10.4M Jun/2026
Boston Scientific USD 1.23B 90M Jun/2026
Cooper Companies USD 233.3M 7.5M Mar/2026
Danaher USD 2.07B 282M Jun/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 210.5M 29.4M Jun/2026
Globus Medical USD 103.66M 4.81M Mar/2026
Insulet USD 123.3M 26.5M Jun/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 1.92B 66.6M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Medtronic USD 2.57B 12M Dec/2025
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Smith & Nephew USD 1.62B 426M Jun/2026
Solventum Corp USD 701M 2M Jun/2026
Stryker USD 1.59B 207M Mar/2026
Tandem Diabetes Care USD 59.86M 12.79M Mar/2026
Teleflex USD 143.29M 335K Jun/2026
Terumo JPY 89.76B 7.73B Mar/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
Zimmer Biomet Holdings USD 352.4M 8.8M Jun/2026